Growth Metrics

Forte Biosciences (FBRX) Total Debt (2016 - 2019)

Historic Total Debt for Forte Biosciences (FBRX) over the last 4 years, with Q2 2019 value amounting to $22.1 million.

  • Forte Biosciences' Total Debt fell 1479.57% to $22.1 million in Q2 2019 from the same period last year, while for Jun 2019 it was $22.1 million, marking a year-over-year decrease of 1479.57%. This contributed to the annual value of $26.2 million for FY2018, which is 62278.62% up from last year.
  • As of Q2 2019, Forte Biosciences' Total Debt stood at $22.1 million, which was down 1479.57% from $24.1 million recorded in Q1 2019.
  • Forte Biosciences' Total Debt's 5-year high stood at $26.2 million during Q4 2018, with a 5-year trough of $2.0 million in Q1 2018.
  • In the last 4 years, Forte Biosciences' Total Debt had a median value of $10.2 million in 2016 and averaged $14.6 million.
  • Per our database at Business Quant, Forte Biosciences' Total Debt crashed by 7702.44% in 2018 and then skyrocketed by 112408.72% in 2019.
  • Over the past 4 years, Forte Biosciences' Total Debt (Quarter) stood at $10.2 million in 2016, then plummeted by 64.6% to $3.6 million in 2017, then skyrocketed by 622.79% to $26.2 million in 2018, then dropped by 15.73% to $22.1 million in 2019.
  • Its last three reported values are $22.1 million in Q2 2019, $24.1 million for Q1 2019, and $26.2 million during Q4 2018.